Compare companies
Bristol-Myers | Humana | Johnson & Johnson | ||||
---|---|---|---|---|---|---|
Capitalization | ||||||
Price | 59.19 | 273.77 | 161.02 | |||
Price priv. | ||||||
Number of shares, million | 2078 | 124.44 | 2560.4 | |||
Capitalization, billion | 129.65 | 60.76 | 448.3 | |||
EBITDA, billion | 19.18 | 4.73 | 29.34 | |||
EV, billion | 138.66 | 63.97 | 405.51 | |||
Profit and loss report | ||||||
Net profit, billion | 8.03 | 2.49 | 35.15 | |||
Revenue, billion | 45.01 | 106.37 | 85.15 | |||
EPS | 3.86 | 20 | 13.73 | |||
Balance | ||||||
Assets, billion | 95.16 | 47.07 | 167.56 | |||
Debt, billion | 39.93 | 11.83 | 29.33 | |||
Balance cost, billion | 29.43 | 16.26 | 68.77 | |||
Cash, billion | 11.46 | 4.69 | 21.86 | |||
Coefficients | ||||||
Dividend yield, % | 4.56 | 1.17 | 3.1 | |||
Dividend | 3.04 | 3.54 | 4.96 | |||
Dividend yield priv., % | 0 | 0 | 0 | |||
Dividend priv. | 0 | 0 | 0 | |||
Dividends/profit, % | 59.12 | 17.32 | 33.48 | |||
P/S | 2.41 | 0.5302 | 4.67 | |||
P/BV | 3.69 | 1.53 | 5.79 | |||
P/E | 13.54 | 22.66 | 11.32 | |||
Ev/Ebitda | 7.23 | 13.52 | 13.82 | |||
Debt/Ebitda | 2.08 | 2.5 | 0.9998 | |||
Efficiency | ||||||
ROE | 27.27 | 15.31 | 51.11 | |||
ROA | 8.43 | 5.29 | 20.98 | |||
ROIC | 9.09 | -3.8 | 19.19 | |||
Ebitda margin | 42.61 | 4.45 | 34.45 | |||
Net margin | 17.83 | 2.34 | 41.28 | |||
Momentum | ||||||
1 week, price changes | -1.48 % | +2.41 % | -1.21 % | |||
1 month, price changes | +2.26 % | +7.36 % | -1.66 % | |||
3 months, price changes | +2.48 % | +7.14 % | +10.4 % | |||
6 months, price changes | +18.1 % | -12.54 % | -0.2293 % | |||
1 year, price changes | +12.64 % | -21.42 % | +3.37 % | |||
3 years, price changes | -23.33 % | -36.98 % | -11.32 % | |||
5 years, price changes | -3.83 % | -32 % | +3.65 % | |||
10 years, price changes | -19.78 % | +46.86 % | +31.07 % |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription